{"id":"https://openalex.org/W3017148358","doi":"https://doi.org/10.1096/fasebj.2020.34.s1.09328","title":"Simulations of Combination Therapy in Hepatocellular Carcinoma Using a Quantitative Systems Pharmacology Model","display_name":"Simulations of Combination Therapy in Hepatocellular Carcinoma Using a Quantitative Systems Pharmacology Model","publication_year":2020,"publication_date":"2020-04-01","ids":{"openalex":"https://openalex.org/W3017148358","doi":"https://doi.org/10.1096/fasebj.2020.34.s1.09328","mag":"3017148358"},"language":"en","primary_location":{"id":"doi:10.1096/fasebj.2020.34.s1.09328","doi":"https://doi.org/10.1096/fasebj.2020.34.s1.09328","is_oa":false,"landing_page_url":"https://doi.org/10.1096/fasebj.2020.34.s1.09328","pdf_url":null,"source":{"id":"https://openalex.org/S25293849","display_name":"The FASEB Journal","issn_l":"0892-6638","issn":["0892-6638","1530-6860"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The FASEB Journal","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5048835954","display_name":"Richard J. Sov\u00e9","orcid":"https://orcid.org/0000-0003-1491-616X","observed_orcids":["https://orcid.org/0000-0003-1491-616X"]},"institutions":[{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Richard J. Sove","raw_affiliation_strings":["Johns Hopkins University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Johns Hopkins University","institution_ids":["https://openalex.org/I145311948"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001476938","display_name":"Mohammad Jafarnejad","orcid":"https://orcid.org/0000-0002-1550-0011","observed_orcids":["https://orcid.org/0000-0002-1550-0011"]},"institutions":[{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mohammad Jafarnejad","raw_affiliation_strings":["Johns Hopkins University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Johns Hopkins University","institution_ids":["https://openalex.org/I145311948"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100699170","display_name":"Hanwen Wang","orcid":"https://orcid.org/0000-0001-5480-431X","observed_orcids":["https://orcid.org/0000-0001-5480-431X"]},"institutions":[{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Hanwen Wang","raw_affiliation_strings":["Johns Hopkins University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Johns Hopkins University","institution_ids":["https://openalex.org/I145311948"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076456783","display_name":"Mark M. Yarchoan","orcid":"https://orcid.org/0000-0003-4401-0748","observed_orcids":["https://orcid.org/0000-0003-4401-0748"]},"institutions":[{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mark Yarchoan","raw_affiliation_strings":["Johns Hopkins University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Johns Hopkins University","institution_ids":["https://openalex.org/I145311948"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5030268482","display_name":"Aleksander S. Popel","orcid":"https://orcid.org/0000-0002-6706-9235","observed_orcids":["https://orcid.org/0000-0002-6706-9235"]},"institutions":[{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Aleksander S. Popel","raw_affiliation_strings":["Johns Hopkins University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Johns Hopkins University","institution_ids":["https://openalex.org/I145311948"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I145311948"],"apc_list":{"value":2500,"currency":"USD","value_usd":2500},"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"34","issue":"S1","first_page":"1","last_page":"1"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.6977999806404114,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.6977999806404114,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11829","display_name":"Mathematical Biology Tumor Growth","score":0.14030000567436218,"subfield":{"id":"https://openalex.org/subfields/2611","display_name":"Modeling and Simulation"},"field":{"id":"https://openalex.org/fields/26","display_name":"Mathematics"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10073","display_name":"Hepatocellular Carcinoma Treatment and Prognosis","score":0.13590000569820404,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/hepatocellular-carcinoma","display_name":"hepatocellular carcinoma","score":0.9990000128746033},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.871999979019165},{"id":"https://openalex.org/keywords/quantitative-systems-pharmacology","display_name":"quantitative systems pharmacology","score":0.8889999985694885},{"id":"https://openalex.org/keywords/tyrosine-kinase-inhibitors","display_name":"tyrosine kinase inhibitors","score":0.8849999904632568},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.9380000233650208},{"id":"https://openalex.org/keywords/cabozantinib","display_name":"cabozantinib","score":0.906000018119812},{"id":"https://openalex.org/keywords/nivolumab","display_name":"nivolumab","score":1.0},{"id":"https://openalex.org/keywords/cancer-immunotherapy","display_name":"cancer immunotherapy","score":0.7900000214576721},{"id":"https://openalex.org/keywords/drug-interactions","display_name":"drug interactions","score":0.5730000138282776},{"id":"https://openalex.org/keywords/antitumor-immunity","display_name":"antitumor immunity","score":0.4860000014305115},{"id":"https://openalex.org/keywords/regulatory-t-cells","display_name":"regulatory T cells","score":0.7749999761581421},{"id":"https://openalex.org/keywords/effector-t-cells","display_name":"effector T cells","score":0.7440000176429749},{"id":"https://openalex.org/keywords/antigen-presenting-cells","display_name":"antigen-presenting cells","score":0.8489999771118164},{"id":"https://openalex.org/keywords/pharmacokinetic-modeling","display_name":"pharmacokinetic modeling","score":0.8080000281333923},{"id":"https://openalex.org/keywords/tumor-draining-lymph-nodes","display_name":"tumor-draining lymph nodes","score":0.6629999876022339}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6989758014678955},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.677571713924408},{"id":"https://openalex.org/C2778019345","wikidata":"https://www.wikidata.org/wiki/Q1148337","display_name":"Hepatocellular carcinoma","level":2,"score":0.5522310137748718},{"id":"https://openalex.org/C2780851360","wikidata":"https://www.wikidata.org/wiki/Q21686041","display_name":"Immune checkpoint","level":4,"score":0.5475989580154419},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.4748575687408447},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4629341959953308},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.44831445813179016},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.4174700081348419},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.41132307052612305},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.33469903469085693},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.27816909551620483}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1096/fasebj.2020.34.s1.09328","doi":"https://doi.org/10.1096/fasebj.2020.34.s1.09328","is_oa":false,"landing_page_url":"https://doi.org/10.1096/fasebj.2020.34.s1.09328","pdf_url":null,"source":{"id":"https://openalex.org/S25293849","display_name":"The FASEB Journal","issn_l":"0892-6638","issn":["0892-6638","1530-6860"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The FASEB Journal","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9763000011444092,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4307988451","https://openalex.org/W4393088824","https://openalex.org/W4385839957","https://openalex.org/W4414532222","https://openalex.org/W3038533377","https://openalex.org/W4399597232","https://openalex.org/W3183379795","https://openalex.org/W4417227017","https://openalex.org/W4384616586","https://openalex.org/W4381434610"],"abstract_inverted_index":{"Hepatocellular":[0],"carcinoma":[1],"(HCC)":[2],"is":[3,69,96,351],"a":[4,72,98,143,153,312],"major":[5],"health":[6],"concern":[7],"and":[8,46,76,135,178,188,199,201,205,218,264,270,303,331,350,369,390,404],"despite":[9],"efforts":[10],"to":[11,70,88,92,107,122,168,176,259,289,341,345,354,381,397],"screen":[12],"at\u2010risk":[13],"individuals,":[14],"diagnosis":[15],"often":[16],"occurs":[17],"at":[18,326],"late":[19],"stages":[20],"when":[21],"patients":[22,38,85,102,112],"are":[23,116,129,138,231,257],"no":[24],"longer":[25],"candidates":[26],"for":[27,111,161,315,361,401],"potentially":[28],"curative":[29],"therapies":[30,131],"(i.e.":[31],"surgical":[32],"resection,":[33],"ablation,":[34],"or":[35,409],"transplantation).":[36],"For":[37],"with":[39,113,236],"advanced":[40],"HCC,":[41,114,134,349],"tyrosine":[42],"kinase":[43],"inhibitors":[44,49],"(TKIs)":[45],"immune":[47,77,179,186,209,237,251,267,279,304],"checkpoint":[48,78,252,268,280,305],"may":[50,378],"provide":[51],"clinical":[52,67,292],"benefit,":[53],"but":[54],"overall":[55],"survival":[56],"remains":[57],"low.":[58],"One":[59],"strategy":[60],"that":[61,86,164,323,377],"has":[62],"shown":[63],"promise":[64],"in":[65,133,141,174,191,239,273,321,375,388],"on\u2010going":[66,291],"trials":[68],"administer":[71],"combination":[73,89,299,359],"of":[74,84,101,145,172,207,227,250,266,297,300,318,348,358,371,384,394],"TKIs":[75],"inhibitors.":[79],"Despite":[80],"the":[81,130,170,203,225,240,244,247,261,271,274,278,285,298,316,327,346,352,356,367,372,382,385,392],"increased":[82],"number":[83],"respond":[87],"therapy":[90,109,360],"compared":[91],"individual":[93,406],"therapies,":[94,398],"there":[95,115],"still":[97],"large":[99],"fraction":[100],"who":[103],"remain":[104],"unresponsive.":[105],"Therefore,":[106],"improve":[108],"outcomes":[110],"two":[117],"broad":[118],"questions":[119],"which":[120,127,230],"need":[121],"be":[123,166,339],"addressed.":[124],"First,":[125],"through":[126],"mechanisms":[128],"interacting":[132],"secondly,":[136],"why":[137],"they":[139],"effective":[140],"only":[142],"subset":[144],"patients?":[146],"To":[147],"address":[148],"these":[149],"questions,":[150],"we":[151],"developed":[152],"mechanistic":[154],"quantitative":[155],"systems":[156],"pharmacology":[157],"(QSP)":[158],"modeling":[159],"platform":[160,314],"immuno\u2010oncology":[162],"(IO)":[163],"can":[165,337],"used":[167,258,340],"predict":[169,342,355],"progression":[171],"HCC":[173,376],"response":[175,344,396],"molecular":[177],"therapies.":[180],"This":[181,335],"model":[182,245,260,275,286],"integrates":[183],"cancer":[184,389],"growth,":[185],"response,":[187],"intracellular":[189],"signaling":[190],"four":[192],"compartments":[193],"(tumor,":[194],"tumor\u2010draining":[195],"lymph":[196],"node,":[197],"central":[198],"peripheral),":[200],"considers":[202],"interactions":[204,235,374,387],"transport":[206,263],"various":[208],"cells":[210,217,229,238],"(e.g.":[211],"effector":[212],"T":[213,215],"cells,":[214],"regulatory":[216],"antigen":[219],"presenting":[220],"cells)":[221],"as":[222,224],"well":[223],"growth":[226],"tumor":[228,241,330],"partially":[232],"dictated":[233],"by":[234,276,413],"compartment.":[242],"Additionally,":[243,364],"includes":[246],"binding":[248],"kinetics":[249],"proteins.":[253,281],"Further,":[254],"pharmacokinetic":[255],"models":[256,320],"uptake,":[262],"clearance":[265],"inhibitors,":[269],"antibodies":[272],"bind":[277],"In":[282],"this":[283,309],"work,":[284],"was":[287],"applied":[288],"an":[290],"trial":[293],"(ClinicalTrials.gov":[294],"Identifier:":[295],"NCT03299946)":[296],"TKI,":[301],"cabozantinib":[302],"inhibitor,":[306],"nivolumab.":[307],"Overall,":[308],"work":[310],"presents":[311],"modular":[313],"development":[317],"QSP":[319],"IO":[322],"integrate":[324],"features":[325],"molecular,":[328],"cellular,":[329],"whole":[332],"patient":[333,395,402],"scales.":[334],"framework":[336],"then":[338],"therapeutic":[343],"treatment":[347],"first":[353],"outcome":[357],"liver":[362],"cancer.":[363],"it":[365],"enables":[366],"analysis":[368],"interpretation":[370],"complex":[373],"ultimately":[379],"lead":[380],"understanding":[383],"drug":[386],"enable":[391],"prediction":[393],"facilitating":[399],"planning":[400],"cohorts":[403],"even":[405],"patients.":[407],"Support":[408],"Funding":[410],"Information":[411],"Supported":[412],"NIH":[414],"grant":[415],"U01CA212007.":[416]},"counts_by_year":[],"updated_date":"2026-09-22T06:50:58.402377","created_date":"2020-04-24T00:00:00"}